Sale!

Harvard Diabetes Comorbidities and Complications 2023

Original price was: $900.97.Current price is: $99.97.

Harvard Diabetes Comorbidities and Complications 2023
You're watching: Harvard Diabetes Comorbidities and Complications 2023
Original price was: $900.97.Current price is: $99.97.
Original price was: $1,500.97.Current price is: $249.97.
Original price was: $900.97.Current price is: $149.97.
Original price was: $900.97.Current price is: $149.97.
Original price was: $1,500.97.Current price is: $149.97.
Original price was: $1,475.97.Current price is: $179.97.
Original price was: $1,475.97.Current price is: $179.97.
Original price was: $1,395.00.Current price is: $149.97.
Original price was: $1,395.00.Current price is: $149.97.
Total: $99.97
Guaranteed Safe Checkout

Please note that there are no CME points or certificate associated with this course.

  • 24/7 support available
  • Payments are sucure and encrypted
HARVARD • DIABETES COMORBIDITIES & COMPLICATIONS • 2023 EDITION

Harvard Diabetes Comorbidities and Complications 2023

A comprehensive Harvard medical course focused on state-of-the-art approaches to assessment, risk reduction, and management of diabetes-related comorbidities and complications, with practical updates for clinicians caring for patients with complex metabolic, cardiovascular, renal, hepatic, and vascular disease.

2023Edition
DiabetesComorbidities
RiskReduction
RecordedCourse
Cardiovascular Risk
Kidney Disease
Obesity & NAFLD
GLP-1 & SGLT-2
Course Details:
Harvard Diabetes Comorbidities and Complications 2023 is a recorded medical course designed to help clinicians optimize care for patients with diabetes and related complications through updated assessment strategies, risk reduction approaches, pharmacologic therapy selection, lifestyle medicine, technology updates, and patient-centered management.

Focus: Obesity, cardiovascular disease, heart failure, coronary artery disease, hypertension, hyperglycemia, hypoglycemia, dyslipidemia, non-alcoholic fatty liver disease, peripheral vascular disease, chronic kidney disease, sexual dysfunction, pregnancy, glucose monitors, insulin pumps, diabetes apps, and health equity.

About This Course

Diabetes care is no longer limited to glucose control alone. Modern management requires a broader view of cardiovascular risk, renal protection, obesity treatment, hepatic disease, vascular complications, medication interactions, technology use, and individualized treatment targets.

This course provides practical education focused on advancing knowledge of diabetes comorbidities and complications, improving evaluation and management, optimizing clinical decision-making, and improving patient outcomes in day-to-day clinical practice.

Why Choose This Course

Key Highlights

  • Comprehensive Harvard update on diabetes comorbidities and complications
  • Focused on state-of-the-art assessment, risk reduction, and management
  • Covers cardiovascular disease, heart failure, coronary artery disease, hypertension, CKD, NAFLD, obesity, and peripheral vascular disease
  • Reviews practical recommendations for GLP-1 RA, SGLT-2 inhibitors, and MRA therapies
  • Includes advances in glucose monitors, insulin pumps, diabetes apps, and insulin therapy
  • Addresses lifestyle medicine, pregnancy, sexual dysfunction, medication interactions, and health equity
  • Useful for endocrinologists, internists, family physicians, primary care clinicians, hospitalists, NPs, PAs, nurses, pharmacists, residents, and fellows

Core Learning Areas

Cardiovascular & Renal Risk Cardiovascular risk assessment, renal risk evaluation, heart failure, coronary artery disease, CKD, kidney disease prevention, and combined therapies.
Modern Pharmacologic Care GLP-1 RA, SGLT-2 inhibitors, MRA, insulin therapy, traditional therapies, innovative therapeutic combinations, and medication interaction prevention.
Metabolic & Vascular Complications Obesity, hypertension, dyslipidemia, peripheral vascular disease, non-alcoholic fatty liver disease, hyperglycemia, hypoglycemia, and sexual dysfunction.
Technology, Lifestyle & Equity Glucose monitors, insulin pumps, diabetes apps, lifestyle medicine, behavioral change, pregnancy, risk assessment, diverse patient needs, and health equity.

Complete Curriculum

Diabetes Comorbidities and Complications Overview

  • State-of-the-art approaches to diabetes comorbidity assessment
  • Risk reduction strategies for patients with diabetes
  • Management of interacting comorbidities
  • Optimizing clinical decision-making
  • Improving patient outcomes through practical clinical updates
  • Applying recent recommendations to day-to-day practice

Cardiovascular Disease, Heart Failure and Coronary Disease

  • Evaluating cardiovascular risk in patients with diabetes
  • Diagnosis and management of coronary artery disease in diabetes
  • Heart failure management in patients with diabetes
  • Improving functional capacity with combined therapies
  • Expanded roles of SGLT-2 inhibitors, MRA, and GLP-1 RA in cardiovascular disease
  • Cardiometabolic risk reduction strategies

Chronic Kidney Disease and Renal Protection

  • Evaluating renal risk in patients with diabetes
  • Evaluating, managing, and monitoring diabetic CKD
  • Management and prevention of kidney disease
  • Expanded roles of SGLT-2 inhibitors and MRA in renal disease
  • Adjusting pharmacological therapies in patients with diabetes complications
  • Coordinated care for patients with diabetes and kidney disease

Hypertension, Dyslipidemia and Vascular Disease

  • Hypertension management in patients with diabetes
  • Cholesterol management and dyslipidemia updates
  • Customizing targets and treatment strategies for each patient
  • Peripheral vascular disease in patients with diabetes
  • New methods for managing vascular complications
  • Reducing long-term cardiovascular and vascular risk

Obesity, NAFLD and Lifestyle Medicine

  • Obesity management in patients with diabetes
  • When to consider new therapeutic options for obesity
  • When to consider surgical options for obesity management
  • Current guidelines for treating non-alcoholic fatty liver disease
  • Lifestyle medicine interventions
  • Helping patients initiate and sustain healthy behavioral changes

Hyperglycemia, Hypoglycemia and Insulin Therapy

  • Prevention and management of hyperglycemia
  • Updates in prevention and management of hypoglycemia
  • Important developments in insulin therapy
  • Combining innovative therapeutic combinations with traditional approaches
  • Using treatment adjustments to reduce adverse outcomes
  • Individualizing therapy for complex diabetes cases

GLP-1 RA, SGLT-2 Inhibitors and MRA

  • Practical recommendations for the use of GLP-1 RA
  • Practical recommendations for the use of SGLT-2 inhibitors
  • Practical recommendations for the use of MRA therapy
  • Expanded roles of these therapies in cardiovascular disease
  • Expanded roles of these therapies in renal disease
  • Therapeutic selection based on comorbidity profile

Diabetes Technology and Innovation

  • Advances in glucose monitors
  • Advances in insulin pumps
  • Diabetes apps and digital diabetes care
  • Using technology to improve diabetes management
  • Innovation in stem cell therapies for diabetes patients
  • Integrating new tools with traditional diabetes care

Pregnancy, Sexual Dysfunction and Special Topics

  • Diabetes in pregnancy
  • New diagnosis and treatment guidelines for pregnancy-related diabetes care
  • Evaluation and management of sexual dysfunction in patients with diabetes
  • Medication interactions and avoiding adverse outcomes
  • Strategies to assess and manage interacting comorbidities
  • Complex patient-centered diabetes decision-making

Health Equity and Diverse Patient Populations

  • Social, racial, sexual, and cultural differences in diabetes care needs
  • Management of diabetes and related disorders in diverse racial and ethnic populations
  • Recognizing biases in diabetes care
  • Strategies for achieving equity and addressing disparities
  • Establishing and maintaining meaningful connections with patients
  • Improving access, adherence, and long-term outcomes

Learning Objectives

By Completing This Course, You Will Be Able To:

  • Evaluate cardiovascular and renal risk in patients with diabetes
  • Adjust pharmacological therapies in patients with diabetes complications
  • Evaluate, manage, and monitor diabetic chronic kidney disease
  • Apply practical recommendations for GLP-1 RA, SGLT-2 inhibitors, and MRA therapy
  • Customize hypertension and cholesterol targets for individual patients
  • Improve management of obesity, NAFLD, peripheral vascular disease, and sexual dysfunction in diabetes
  • Use advances in glucose monitors, insulin pumps, and diabetes apps to support patient care
  • Incorporate lifestyle medicine and health equity strategies into diabetes management
  • Recognize medication interactions and reduce adverse outcomes in complex patients

Who Should Take This Course

This course is designed for endocrinologists, internists, family physicians, primary care physicians, hospitalists, cardiologists, nephrologists, diabetes educators, pharmacists, nurse practitioners, physician assistants, nurses, residents, fellows, and healthcare professionals involved in diabetes care and complication prevention.

Delivery & Access

Recorded Course Review the diabetes comorbidities and complications sessions at your own pace.
2023 Edition State-of-the-art approaches to assessment, risk reduction, and management.
Clinical Focus Cardiovascular, renal, hepatic, vascular, metabolic, lifestyle, and technology updates.
Important Note:
This course package is provided for recorded learning access. No CME points are associated with this product.

Reviews

★★★★★
Dr. Emily Carter

A strong diabetes complications update. The cardiovascular, renal, GLP-1, SGLT-2, and obesity sections are especially useful for clinical practice.

★★★★★
Dr. Michael Thompson

Excellent course for clinicians managing complex diabetes patients. The comorbidity-focused approach makes the content very practical.

★★★★★
Dr. Sarah Patel

Well organized and clinically relevant. The course gives clear strategies for risk reduction, medication selection, and complication prevention.

FAQ

Who is this course best suited for?

It is ideal for endocrinologists, internists, family physicians, primary care physicians, hospitalists, cardiologists, nephrologists, diabetes educators, pharmacists, NPs, PAs, nurses, residents, fellows, and clinicians involved in diabetes care.

What topics are covered?

The course covers obesity, cardiovascular disease, heart failure, coronary artery disease, hypertension, hyperglycemia, hypoglycemia, dyslipidemia, non-alcoholic fatty liver disease, peripheral vascular disease, chronic kidney disease, sexual dysfunction, pregnancy, glucose monitors, insulin pumps, diabetes apps, GLP-1 RA, SGLT-2 inhibitors, MRA, lifestyle medicine, stem cell therapies, medication interactions, and health equity.

Is this course practical for daily diabetes care?

Yes. The course focuses on assessment, risk reduction, management strategies, pharmacologic therapy selection, lifestyle interventions, technology updates, and practical recommendations for patients with diabetes and related complications.

Does this product include CME?

No. This course package does not include CME points.

Who can I contact for support?

You can contact us at [email protected].

Reviews

There are no reviews yet.

Be the first to review “Harvard Diabetes Comorbidities and Complications 2023”

Reviews

There are no reviews yet.

Be the first to review “Harvard Diabetes Comorbidities and Complications 2023”
Shopping Cart
SWEET! Add more products and get $0.00 per Product off on your entire order! WHEN YOU SPEND 100$
X

New item(s) have been added to your cart.

Frequently bought with Harvard Diabetes Comorbidities and Complications 2023


Harvard Update in Clinical Cardiology 2025 (Videos + Slides PDFs) Original price was: $895.97.Current price is: $149.97.
Harvard Anesthesiology Update 2025 Original price was: $1,500.97.Current price is: $169.97.
AdventHealth Orlando Live Endoscopy 2026 Original price was: $900.97.Current price is: $149.97.
Harvard Update on Severe Asthma 2025 Original price was: $900.97.Current price is: $149.97.
Harvard Clinical Endocrinology 2025 Original price was: $1,300.97.Current price is: $149.97.
Harvard 46th Annual Intensive Review of Internal Medicine 2023 Original price was: $950.97.Current price is: $99.97.
Harvard Psychopharmacology: A Master Class 2023 Original price was: $700.97.Current price is: $99.97.
Harvard Dermatopathology Update 2025 Original price was: $900.97.Current price is: $149.97.
Scroll to Top